![]() |
|
|
Molecular Pharmacology, Vol 20, 345-355, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics
1 Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore,
Maryland 21201, Department of Pharmacology, Mount Sinai School of Medicine of the City University of New York, New
York, New York 10029, and Laboratory of Bioorganic Chemistry, National Institute of Arthritis, Metabolism, and Digestive
Diseases, National Institutes of Health, Bethesda, Maryland 20205
The actions of several quaternary molecules on the end plate region of the frog sartorius
muscle were studied using bath application or intracellular injection. Tetraethylammonium (TEA), atropine methyl bromide, phencyclidine methiodide (PCP methiodide),
piperocaine methiodide, and N-methyl piperidine methiodide were injected into the
sarcoplasm just beneath the postjunctional membrane and 250-350 µm away from the
end plate region. The ability of these agents to depress potassium conductance and
prolong the muscle action potential was used as a measure of the efficacy of intracellular
drug administration. External application of TEA (50-1000 µM) decreased the peak
amplitude of the end plate current (EPC) and its time constant of decay (
EPC), but this
agent and atropine methyl bromide were ineffective when injected internally. PCP
methiodide (3-30 µM) and piperocaine methiodide (10-60 µM) had a potent action on
EPCs and spontaneous miniature end plate currents (MEPCs) when applied to either
side of the membrane. Both agents caused nonlinearity of the peak amplitude and a
shortened channel lifetime in spite of the fact that they sense only 6% of the membrane
potential at their rate-limiting energy barrier. Internal application of PCP methiodide
caused significant depression of the EPC and MEPC peak amplitude and simultaneous
shortening of MEPC decay time constant. The decay time constant of the EPC and
MEPC in the presence of PCP methiodide and piperocaine methiodide was shorter at
less negative (i.e., -60 mV) than at more negative (i.e., -100 mV) membrane potentials.
Similar results were obtained with internal applications of piperocaine methiodide. N-methyl piperidine methiodide, a quaternary contaminant of PCP methiodide, did not
display any effect when it was applied inside the cell. The results indicate that sites
controlling the ionic channel of the acetylcholine receptor from the external surface may
be significantly different from sites on the internal surface, even though both sites do
interact with certain quaternary amines. These findings further indicate that the ionic
channel is asymmetrical with the selectivity gate located most likely at the intracellular
region of the channel. Finally, it is suggested that the decay time constant of the ionic
currents in the presence of tertiary agents may be an average, voltage-dependent result
of the actions of the agent inside and outside the cell.
Note:
ACKNOWLEDGMENTS
The authors are grateful to Professor David Triggle for the gift of
PCP methiodide. We are most indebted to Dr. Harel Weinstein and
Dr. Saul Mayaani for the most valuable suggestions for and criticisms
of the manuscript. We are also grateful to Dr. Daniel Weinreich for the
technical suggestions regarding intracellular release of drugs. The expert computer analysis and general technical assistance of Ms. Mabel
Zelle are greatly appreciated.